By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Z-drug hypnotic > Zopiclone

Zopiclone

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|632 words

Zopiclone: Sleep Medication Profile

What is Zopiclone?

Zopiclone is a prescription sleep medication belonging to a class of drugs called Z-drugs or non-benzodiazepine hypnotics. It is primarily used to treat short-term insomnia and other sleep disorders by helping patients fall asleep faster and maintain sleep throughout the night. Zopiclone works similarly to benzodiazepines but has a different chemical structure and is designed to have fewer side effects.

Uses

  • Short-term insomnia treatment: Primary indication for difficulty falling asleep or staying asleep, typically prescribed for 2-4 weeks maximum
  • Sleep initiation problems: Helps patients who struggle to fall asleep within a reasonable time frame
  • Sleep maintenance issues: Reduces frequent nighttime awakenings and early morning awakening
  • Situational sleep disturbances: May be prescribed for temporary sleep problems due to stress, travel, or environmental changes
  • Pre-operative sedation: Occasionally used as a pre-anesthetic medication to help patients sleep before surgery

How it works

Zopiclone enhances the activity of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter, by binding to specific GABA receptors in the central nervous system. This increased GABA activity produces a calming, sedative effect that promotes sleep onset and maintenance. Unlike older sleep medications, zopiclone selectively targets certain GABA receptor subtypes, which may result in more targeted sleep effects with potentially fewer muscle relaxant and memory-impairing properties.

Side effects

Common side effects:

  • Metallic or bitter taste in mouth (very common)
  • Drowsiness or fatigue the next day
  • Dizziness or lightheadedness
  • Dry mouth
  • Headache
  • Nausea or stomach upset
  • Memory problems or confusion
  • Coordination difficulties

Serious side effects to watch for:

Submit Your Paper
GMJ_Submit_Banner
  • Complex sleep behaviors (sleepwalking, sleep-driving, sleep-eating)
  • Severe allergic reactions with swelling of face, lips, or throat
  • Significant mood changes, depression, or suicidal thoughts
  • Severe memory loss or amnesia
  • Signs of physical dependence or withdrawal symptoms

Warnings and precautions

  • Dependency risk: Zopiclone can be habit-forming, especially with long-term use or higher doses, and should only be used for short periods as prescribed
  • Respiratory depression: Should be avoided in patients with severe respiratory conditions, sleep apnea, or myasthenia gravis due to risk of breathing difficulties
  • Pregnancy and breastfeeding: Not recommended during pregnancy or while breastfeeding as it may affect fetal development and pass into breast milk
  • Liver impairment: Dose reduction may be necessary in patients with liver disease as the drug is metabolized by the liver
  • Elderly patients: Increased sensitivity to side effects, higher fall risk, and slower drug clearance require careful monitoring and often lower doses

Interactions

  • Alcohol: Significantly increases sedation, respiratory depression risk, and impairs coordination and judgment
  • Opioid pain medications: Combined use increases risk of severe sedation, respiratory depression, and potentially fatal overdose
  • Benzodiazepines: Additive sedative effects increase fall risk and respiratory depression when used together
  • Antihistamines: Over-the-counter allergy and sleep aids can enhance drowsiness and cognitive impairment
  • Antidepressants: Certain antidepressants may increase zopiclone levels or add to sedative effects
  • Muscle relaxants: Combined use increases risk of excessive sedation and impaired motor function
  • Rifampin: This antibiotic may reduce zopiclone effectiveness by increasing its metabolism
  • Erythromycin and ketoconazole: These medications may increase zopiclone levels by inhibiting its breakdown

Check interactions with the GMJ Interaction Checker

Dosage

The typical adult dose of zopiclone is 7.5 mg taken orally once daily, approximately 30 minutes before bedtime. For elderly patients or those with liver impairment, the recommended starting dose is usually reduced to 3.75 mg daily. The medication should be taken only when the patient can dedicate 7-8 hours to sleep to avoid next-day drowsiness. Treatment duration should generally not exceed 2-4 weeks to minimize the risk of dependence. Dosage should always be determined by a healthcare provider based on individual patient factors, medical history, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Zopiclone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/zopiclone/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Magnesium’s hidden role in insulin signalling: why the mineral matters for glucose control

Magnesium acts as a critical molecular switch in insulin signalling. New analysis…

Why the same bread raises blood sugar differently in different people

Researchers at the Weizmann Institute found that identical carbohydrate meals produce glucose…

Vitamin D dose response is not linear: Why shelf-picked supplements may not work as expected

Vitamin D supplements do not work the same way for everyone. Research…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Eszopiclone

By
Prof. Giorgi Pkhakadze
02/06/2026

Zolpidem

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up